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Abstract 
Chronic obstructive pulmonary disease (COPD) is an important issue of the contemporary medicine. 
Comorbid conditions are some of the factors that adversely impact the disease progression. Currently, 
researchers place more emphasis on the study of mental disorders that are quite common in COPD patients. 
Aim: to perform a comparative analysis of detection of mental disorders in COPD patients by using the 
questionnaire data and findings of psychiatric examination. 
Materials and Methods: we have examined 56 COPD patients. Patients examination included general 
clinical methods, questionnaires for detecting of mental disorders, psychiatrist examination. 
Results: the psychiatrist confirmed the findings for nearly a half of the patients who, according to the 
questionnaires, had no symptoms of mental disorders; however, more than a half of the patients had various 
mental disorders though they were not depression and/or anxiety.  
At the same time for most COPD patients who, according to the questionnaires, had symptoms of 
depression and/or anxiety, mental disorders were also confirmed by the psychiatrist, though they were not 
always depression/anxiety, and no mental disorders were detected in a quarter of patients. 
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1. Introduction 
Chronic obstructive pulmonary disease (COPD) is an important issue of the contemporary 
medicine. Though a range of treatment options is presently available, the condition remains an 
important cause of mortality. Additionally, COPD often results in decreased capacity and 
deterioration of patient quality of life. Comorbid conditions are some of the factors that 
adversely impact the disease progression [1, 2, 3]. Currently, researchers place more emphasis on 
the study of mental disorders that are quite common in COPD patients [4]. 
According to a number of studies, occurrence of mental disorders in COPD patients varies 
significantly depending on the research method and categories of subjects: 7 to 80% for 
depression and 10 to 100% for anxiety. COPD can also be associated with other types of mental 
disorders such as emotionally labile disorder, asthenoneurotic syndrome, asthenic syndrome, 
etc. [4, 5, 6]. 
Mental disorders are known to adversely impact COPD patients who experience more relapses, 
reduced quality of life, are less committed to treatment, etc. [5, 7, 8, 9]. 
This study was aimed to perform a comparative analysis of detection of mental disorders in 
COPD patients by using the questionnaire data and findings of psychiatric examination. 
 
2. Materials and Methods 
We have examined 56 COPD patients (46 (82.1±5.1%) men, 10 (17.9±5.1%) women; mean age 
was 63.9±1.0 years, level of forced expiratory volume in one second (FEV1) was 51.9±2.2% 
pred., mean COPD Assessment Test (CAT) score was 15.7±1.0). 
Clinical diagnosis of COPD was formulated in accordance with Order No.555 of the Ministry 
of Health of Ukraine dated June 27, 2013 [2]. 
All patients were in a stable phase of COPD for at least two previous months and received 
therapy according to their clinical groups pursuant to Order No.555 of the Ministry of Health of 
Ukraine dated June 6, 2013 [2]. 
All patients signed informed consent forms for participation in the study. 
Patients examination included general clinical methods (review of complaints, case history, life 
history), assessment of clinical symptoms, including by using the CAT questionnaire [1, 2]. 
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The study conducted in two stages. 
At the first stage, patient mental assessment was performed with 
the Patient Health Questionnaire 9 (PHQ-9) [10, 11], Hospital 
Anxiety and Depression Scale (HADS), a test used to determine 
HADS-depression and HADS-anxiety in somatic patients [10, 12], 
and the Beck Depression Inventory-Short Form (BDI-SF) [13]. 
At the second stage, a final mental state assessment of all 
patients was performed by a psychiatrist who applied clinical 
anamnestic, psychopathological and psychodiagnostic methods 
[10]. 
For statistical analysis of the results we used biometric analysis 
methodology supported by STATISTICA 6.1 software. Normal 
distribution was analysed by the mean value and mean error 
while non-normal distribution was analysed by the median and 
quartiles (Me [25-75]) [14]. 
 
3. Results and Discussion 
The survey of COPD patients we conducted at the first stage of 
the study indicated that the findings have some — sometimes 
quite substantial — differences when assessed by various 
scales. For instance, by the PHQ-9 depression was detected in 
less than a fifth of the subjects and in more than a third of 
patients when assessed by the HADS and BDI-SF tests (Table 
1). Moreover, the severity of depression as assessed by the 
PHQ-9 and HADS was mainly mild (mean score 8 [8-12] and 10 
[8-11], respectively), however, the BDI-SF test showed that it was 
mostly moderate (mean score 9 [6.5–10.5]). 
 
Table 1: Incidence of depression in COPD patients as assessed by 
different questionnaires 
 
Questionnaire Number of patients abs. % 
PHQ-9 11 19.6 
HADS-depression 17 30.4 
BDI-SF 20 35.7 
 
Thus, it was found that the same COPD patients had somewhat 
different presence and severity of depression results obtained 
from different questionnaires. 
According to the HADS, anxiety was found in 9 (16.1%) and 
was mild in severity (mean score 9) [8-10]. 
It should be noted that, according to the above questionnaires, 
26 of 56 patients we have examined did not have any depression 
or anxiety, and 30 persons had signs of depression and/or 
anxiety as assessed by at least one of the tests. 
At the second stage of the study, the psychiatrist consulted all 
56 patients to verify their diagnoses. It was found that 12 
(46.2%) of 26 patients who, according to the questionnaires, had 
no mental disorders, did not actually have any of them while six 
(23.0%) patients had asthenic syndrome, three (11.5%) patients 
had mild somatoform autonomic dysfunction and emotionally 
labile disorder, one (3.8%) had asthenoneurotic syndrome and 
cognitive impairment caused by cerebral arteriosclerosis. 
Therefore, the psychiatrist confirmed the findings for nearly a 
half of the patients who, according to the questionnaires, had no 
symptoms of mental disorders; however, more than a half of the 
patients had various mental disorders though they were not 
depression and/or anxiety. 
Of 30 COPD patients who had signs of depression and/or 
anxiety determined by at least one of the questionnaires, only 
four (13.3%) patients had those disorders as diagnosed by the 
psychiatrist (mixed anxiety-depressive disorder, mild 
depressive disorder, histrionic personality disorder and anxiety 
disorder); 11 (36.6%) of them had cognitive impairment caused 
by cerebral atherosclerosis, 6 (20.0%) patients had asthenic 
syndrome, asthenoneurotic syndrome and emotionally labile 
disorders. In a quarter (7 (23.3%)) of patients no psychiatric 
disorders were found. Therefore, for most COPD patients who, 
according to the questionnaires, had symptoms of depression 
and/or anxiety, mental disorders were also confirmed by the 
psychiatrist, though they were not always depression/anxiety, 
and no mental disorders were detected in a quarter of patients. 
 
4. Conclusions 
1. mental disorders in COPD patients can be very different by 
nature which cannot be determined only with 
questionnaires; 
2. absence of signs of mental disorders as determined in 
surveying of COPD patients most likely indicates that those 
persons have no major mental disorders; 
3. COPD patients with certain complaints or risk factors 
should be examined by a psychiatrist for diagnosis 
specification; 
4. In the event that any signs of mental disorders are detected 
with any of the questionnaires, a psychiatrist should 
examine such patients to verify their diagnoses and 
prescribe treatment as appropriate. 
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